• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate.一名接受甲磺酸伊马替尼治疗的系统性硬化症患者发生暴发性毛细血管渗漏综合征。
Rheumatology (Oxford). 2016 Oct;55(10):1916-8. doi: 10.1093/rheumatology/kew245. Epub 2016 Jun 23.
2
Systemic capillary leak syndrome following bosentan treatment in a patient with systemic sclerosis.一名系统性硬化症患者接受波生坦治疗后出现系统性毛细血管渗漏综合征。
Scand J Rheumatol. 2019 Sep;48(5):426-427. doi: 10.1080/03009742.2019.1584641. Epub 2019 Apr 23.
3
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis.甲磺酸伊马替尼治疗系统性硬化症的疗效与安全性：一项系统评价和荟萃分析
Expert Rev Clin Immunol. 2020 Sep;16(9):931-942. doi: 10.1080/1744666X.2020.1813569. Epub 2020 Oct 3.
4
Newly diagnosed breast cancer in a patient receiving imatinib mesylate.一名正在接受甲磺酸伊马替尼治疗的患者新诊断出乳腺癌。
J Cancer Res Ther. 2014 Oct-Dec;10(4):1107-8. doi: 10.4103/0973-1482.146095.
5
Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia.伊马替尼诱发的费城染色体阳性慢性髓性白血病甲状腺炎
Indian J Pharmacol. 2016 Jul-Aug;48(4):458-459. doi: 10.4103/0253-7613.186214.
6
Hypertrophic osteoarthropathy with imatinib therapy.伊马替尼治疗相关的肥大性骨关节病
Intern Med J. 2015 Oct;45(10):1088-90. doi: 10.1111/imj.12858.
7
A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor.甲磺酸伊马替尼治疗胃肠道间质瘤的安全性评估。
Expert Opin Drug Saf. 2016;15(4):571-8. doi: 10.1517/14740338.2016.1152258. Epub 2016 Feb 27.
8
Imatinib--A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015.伊马替尼——2015年用于慢性髓性白血病一线治疗的新型酪氨酸激酶抑制剂。
JAMA Oncol. 2015 May;1(2):143-4. doi: 10.1001/jamaoncol.2015.50.
9
A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients.一项探索慢性髓性白血病患者中ABCB1、ABCG2、OCT1基因多态性及血药谷浓度与甲磺酸伊马替尼所致血小板减少症相关性的研究。
Cancer Chemother Pharmacol. 2015 Dec;76(6):1185-9. doi: 10.1007/s00280-015-2905-6. Epub 2015 Nov 6.
10
Capillary leak syndrome in a patient treated with interleukin 2 fusion toxin for cutaneous T-cell lymphoma.一名接受白细胞介素2融合毒素治疗皮肤T细胞淋巴瘤的患者出现毛细血管渗漏综合征。
J Am Acad Dermatol. 2001 Feb;44(2):312-3. doi: 10.1067/mjd.2001.110643.

引用本文的文献

1
Diuretic-Resistant Ascites Following Laparoscopic Surgery in a Patient With Chronic Myeloid Leukemia on Imatinib Therapy.伊马替尼治疗的慢性髓性白血病患者腹腔镜手术后出现利尿剂抵抗性腹水
Cureus. 2021 Feb 4;13(2):e13127. doi: 10.7759/cureus.13127.
2
Successful Treatment of Sjögren's Syndrome Presenting as a Condition Similar to Chronic Capillary Leak Syndrome Using Combination Therapy with High-Dose Intravenous Immunoglobulin and Glucocorticoid.采用大剂量静脉注射免疫球蛋白和糖皮质激素联合治疗成功治愈表现为类似慢性毛细血管渗漏综合征的干燥综合征。
Case Rep Rheumatol. 2019 Mar 4;2019:4865024. doi: 10.1155/2019/4865024. eCollection 2019.

本文引用的文献

1
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial.尼洛替尼（达希纳™）治疗早期弥漫性系统性硬化症：一项开放标签的试点临床试验。
Arthritis Res Ther. 2015 Aug 18;17(1):213. doi: 10.1186/s13075-015-0721-3.
2
Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity.冠状动脉微血管周细胞是马来酸舒尼替尼诱导心脏毒性的细胞靶标。
Sci Transl Med. 2013 May 29;5(187):187ra69. doi: 10.1126/scitranslmed.3005066.
3
Therapeutic inhibition of tyrosine kinases in systemic sclerosis: a review of published experience on the first 108 patients treated with imatinib.系统性硬皮病的酪氨酸激酶治疗抑制：108 例伊马替尼治疗患者的经验回顾。
Semin Arthritis Rheum. 2013 Feb;42(4):377-90. doi: 10.1016/j.semarthrit.2012.06.001. Epub 2012 Jul 11.
4
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.癌症治疗药物甲磺酸伊马替尼的心脏毒性。
Nat Med. 2006 Aug;12(8):908-16. doi: 10.1038/nm1446. Epub 2006 Jul 23.
5
Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors.抑制血小板衍生生长因子受体可降低肿瘤间质高血压并增加肿瘤内的跨毛细血管转运。
Cancer Res. 2001 Apr 1;61(7):2929-34.
6
Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis.自身免疫性雷诺现象和系统性硬化症中微血管周细胞的激活
Arthritis Rheum. 1999 May;42(5):930-41. doi: 10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1.
7
Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.血小板源性生长因子B（PDGF-B）缺陷小鼠的周细胞丢失与微动脉瘤形成
Science. 1997 Jul 11;277(5323):242-5. doi: 10.1126/science.277.5323.242.
8
A novel physiological function for platelet-derived growth factor-BB in rat dermis.血小板衍生生长因子-BB在大鼠真皮中的一种新的生理功能。
J Physiol. 1996 Aug 15;495 ( Pt 1)(Pt 1):193-200. doi: 10.1113/jphysiol.1996.sp021584.

Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate.

作者信息

Hinchcliff Monique E, Lomasney Jon, Johnson Julie A, Varga John

机构信息

Department of Medicine Institute for Public Health and Medicine

Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Rheumatology (Oxford). 2016 Oct;55(10):1916-8. doi: 10.1093/rheumatology/kew245. Epub 2016 Jun 23.

DOI:10.1093/rheumatology/kew245
PMID:27338086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5854093/
Abstract
摘要